發佈時間:2024-04-22
安全暢通 緻密相容
佰維思®血管生物補片是尊龙凯时人生就是博醫療繼原有心外科生物補片、胸外科生物補片、硬腦(脊)膜補片和生物疝補片之後的又一生物補片產品,填補國內空白的上市產品。期待能讓廣大患有頸動脈粥樣硬化的患者獲得及時有效的治療,以預防腦卒中的發生;利用生物補片產品優勢,為外周血管疾病患者提供血管修復新選擇。
文獻來源
[1] Brott TG, Calvet D, Howard G, et al. Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data[J]. Lancet Neurol. 2019;18(4):348-356.
[2] 《中國腦卒中防治指導規範(2021年版)》
[3] AbuRahma AF, Avgerinos ED, Chang RW, et al. Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease[J]. J Vasc Surg. 2022;75(1S):4S-22S.
[4] Naylor R, Rantner B, Ancetti S, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease[J]. Eur J Vasc Endovasc Surg. 2023;65(1):7-111.
[5] Edenfield L, Blazick E, Eldrup-Jorgensen J, et al. Outcomes of carotid endarterectomy in the Vascular Quality Initiative based on patch type[J]. J Vasc Surg. 2020;71(4):1260-1267.